Leukocyte-lymphatic intersections during cardiac inflammation

Kristofor Glinton, Abhishek V. Thakkar, Rebecca Jones, Hiroyasu Inui, Zhi Dong Ge, Edward B. Thorp*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Advances in genetic, pharmacologic, and sequencing technology have led to new insight into the role of lymphatics in health and disease. This includes fundamental aspects of the crosstalk between immune cells with cardiac lymphatics. At the interface between leukocytes and lymphatic endothelial cells, myeloid populations are sources of lymphatic growth factors during inflammation. Lymphatic endothelial cells also secrete signals that activate leukocytes, including to antigen presenting cells. Taken together, a view of the lymphatic vasculature as a supplemental cardiac immune hub is emerging. Herein, we discuss reciprocal cell and molecular crosstalk between leukocytes and lymphatics in the myocardium, with implications for health and cardiac inflammation.

Original languageEnglish (US)
Pages (from-to)13-20
Number of pages8
JournalJournal of Molecular and Cellular Cardiology
Volume198
DOIs
StatePublished - Jan 2025

Funding

Supported by NIH R01HL122309 and by the Sidney and Bess Eisenberg Memorial Endowment.

Keywords

  • Lymphatic endothelial cell
  • Macrophage
  • Myocardial infarction

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Leukocyte-lymphatic intersections during cardiac inflammation'. Together they form a unique fingerprint.

Cite this